Alkan Akalın, S.; Afşin, Y.; Özdemir, İ.; Tuncer, M.C.; Öztürk, Ş.
Boswellic Acid Enhances Gemcitabine’s Inhibition of Hypoxia-Driven Angiogenesis in Human Endometrial Cancer. Medicina 2025, 61, 2181.
https://doi.org/10.3390/medicina61122181
AMA Style
Alkan Akalın S, Afşin Y, Özdemir İ, Tuncer MC, Öztürk Ş.
Boswellic Acid Enhances Gemcitabine’s Inhibition of Hypoxia-Driven Angiogenesis in Human Endometrial Cancer. Medicina. 2025; 61(12):2181.
https://doi.org/10.3390/medicina61122181
Chicago/Turabian Style
Alkan Akalın, Senem, Yasemin Afşin, İlhan Özdemir, Mehmet Cudi Tuncer, and Şamil Öztürk.
2025. "Boswellic Acid Enhances Gemcitabine’s Inhibition of Hypoxia-Driven Angiogenesis in Human Endometrial Cancer" Medicina 61, no. 12: 2181.
https://doi.org/10.3390/medicina61122181
APA Style
Alkan Akalın, S., Afşin, Y., Özdemir, İ., Tuncer, M. C., & Öztürk, Ş.
(2025). Boswellic Acid Enhances Gemcitabine’s Inhibition of Hypoxia-Driven Angiogenesis in Human Endometrial Cancer. Medicina, 61(12), 2181.
https://doi.org/10.3390/medicina61122181